HER2 (C-ERBB-2) ONCOPROTEIN EXPRESSION IN COLORECTAL ADENOCARCINOMA - AN IMMUNOHISTOLOGICAL STUDY USING 3 DIFFERENT ANTIBODIES

被引:20
作者
ARNAOUT, AH
DAWSON, PM
SOOMRO, S
TAYLOR, P
THEODOROU, NA
FELDMANN, M
FENDLY, BM
SHEPARD, HM
SHOUSHA, S
机构
[1] CHARING CROSS HOSP,DEPT HISTOPATHOL,LONDON W6 8RF,ENGLAND
[2] CHARING CROSS HOSP,DEPT SURG,LONDON W6 8RF,ENGLAND
[3] CHARING CROSS & WESTMINSTER MED SCH,LONDON W6 8RF,ENGLAND
[4] CHARING CROSS SUNLEY MED RES CTR,LONDON,ENGLAND
[5] GENENTECH INC,SAN FRANCISCO,CA 94080
关键词
D O I
10.1136/jcp.45.8.726
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Paraffin wax sections of 70 surgically resected colorectal adenocarcinomas were examined for the overexpression of HER2/c-erbB-2 oncoprotein using three different specific antibodieS and the avidin-biotin immunoperoxidase technique. The patients included 38 men and 32 women aged between 47 and 80 years. The tumours were derived from various parts of the large intestinal tract, and represented all three stages of Dukes' classification and the three histological grades of differentiation. Many tumour sections also included adjacent normal or transitional mucosa. Eight tubular adenomas found in the colectomy specimens in association with some carcinomas were also examined. No positive membrane staining was seen in any of the 70 carcinomas, four adenomas, two hyperplastic polyps, nor in the adjacent normal or transitional mucosa. It is suggested that the overexpression of c-erbB-2 gene product is unlikely to be as common and as pronounced in colorectal adenocarcinoma as it is in ductal carcinoma of the breast.
引用
收藏
页码:726 / 727
页数:2
相关论文
共 11 条
[1]  
DEMILIA J, 1989, ONCOGENE, V4, P1233
[2]  
FENDLY BM, 1990, CANCER RES, V50, P1550
[3]   AMPLIFICATION OF C-MYC AND C-ERBB-2 PROTO-ONCOGENES IN HUMAN SOLID TUMORS - FREQUENCY AND CLINICAL-SIGNIFICANCE [J].
GUTMAN, M ;
RAVIA, Y ;
ASSAF, D ;
YAMAMOTO, T ;
ROZIN, R ;
SHILOH, Y .
INTERNATIONAL JOURNAL OF CANCER, 1989, 44 (05) :802-805
[4]  
MCCANN A, 1990, CANCER, V65, P88, DOI 10.1002/1097-0142(19900101)65:1<88::AID-CNCR2820650119>3.0.CO
[5]  
2-Z
[6]   EXPRESSION OF THE P185 ENCODED BY HER2 ONCOGENE IN NORMAL AND TRANSFORMED HUMAN TISSUES [J].
NATALI, PG ;
NICOTRA, MR ;
BIGOTTI, A ;
VENTURO, I ;
SLAMON, DJ ;
FENDLY, BM ;
ULLRICH, A .
INTERNATIONAL JOURNAL OF CANCER, 1990, 45 (03) :457-461
[7]   ONCOPROTEIN STABILITY AFTER TUMOR RESECTION [J].
ONG, G ;
GULLICK, W ;
SIKORA, K .
BRITISH JOURNAL OF CANCER, 1990, 61 (04) :538-542
[8]   PATHOLOGICAL FINDINGS FROM THE NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT - PROGNOSTIC-SIGNIFICANCE OF ERBB-2 PROTEIN OVEREXPRESSION IN PRIMARY BREAST-CANCER [J].
PAIK, S ;
HAZAN, R ;
FISHER, ER ;
SASS, RE ;
FISHER, B ;
REDMOND, C ;
SCHLESSINGER, J ;
LIPPMAN, ME ;
KING, CR .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (01) :103-112
[9]  
TAL M, 1988, CANCER RES, V48, P1517
[10]   AN EVALUATION OF IMMUNOREACTIVITY FOR C-ERBB-2-PROTEIN AS A MARKER OF POOR SHORT-TERM PROGNOSIS IN BREAST-CANCER [J].
WALKER, RA ;
GULLICK, WJ ;
VARLEY, JM .
BRITISH JOURNAL OF CANCER, 1989, 60 (03) :426-429